I think a lot of people are interested in the
I think a lot of people are interested in the topic
There have been people that have sold warrants to buy stock
There have been people that sold stock to buy warrants
There are people that only buy stock
There are people that only buy warrants
There are people that look at many factors of warrants before making that decision. There are others that just go on gut.
I own both warrants and stock. Before I bought the warrants I looked at the stock price, warrant price, days to maturity, gearing, interest rate, volatility and my favorite average daily volume
It would be hard for a lot here to swap stock for warrants since warrants are low volume
I did think about selling my warrants as interest rates are so cheap, it's a better risk ratio for me if I wanted that kind of leverage but I am not a fan of borrowing money to invest. Warrants is a different way of getting leverage without borrowing, but comes with risk.
Our example of $10 makes buying warrants or stock an easy decision. Even better if you use $50, but there are no guarantees.
Pick any stock and as a harder example. Say the warrant exercise price is $100. Warrant price is $1 and the stock prices is $10 and there are two years left. Would people be buying warrants? I guess it depends on the stock potential.
The example above make Verb warrants seem more attractive as the sp is 2/3 of the way to the warrants being in the money and then you just need it to go up more to your original warrant investment price to break even. So right now about $4.
When/If Verb's revenues start doubling ever year, than some would be kicking themselves for not buying warrants or stock. The potential definitely here and outside of the current investors, most only know a fraction of it.
Which leads me to one point I want to make. How does a company like Verb explain it all in one paragraph, one video or one 20 minute presentation to new investors. Seems a daunting task and not call the cards have been revealed.
Anywho, back to work.
15
TON Strategy Co. (TONX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...
Continue Reading
When Savings Belong to the Next Plan A patient changing insurance plans can turn prevention into nobody’s asset. That is the uncomfortable little engine inside Russell Greenfield’s recent argument: an insurer may pay today for a program that helps prevent chronic illness, only to watch the eventual savings land with another plan after the member moves on. The person...
Continue Reading
Money mistakes get expensive long before anyone calls them mistakes. That is the uncomfortable point beneath Webster First Federal Credit Union CEO John Thomasian's November 20, 2026 discussion of financial literacy: plenty of young adults are entering the real financial world with a card, a loan offer, and a phone full of banking apps, but no sturdy framework for using...
Continue Reading
August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...
Continue Reading
A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...
Continue Reading
Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...
Continue Reading
A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...
Continue Reading
Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...
Continue Reading
GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...
Continue Reading
Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...
Continue Reading
Top 5 Most Recently Viewed Articles
Exploring the Growth of the Beta Glucan Market The beta glucan market is experiencing remarkable growth, largely driven by increasing awareness of its health benefits. More and more consumers are recognizing the importance of supporting their immune systems and managing cholesterol levels, which has led to a surge in demand across numerous sectors, including...
Continue Reading
Transforming Presentations with AiPPT.com In the evolving landscape of digital work, AiPPT.com stands out as a leading provider of AI-native tools that are reshaping the way presentations are crafted. As an advanced AI presentation maker, AiPPT.com is committed to enhancing user experiences by making the process of creating engaging and professional presentations much...
Continue Reading
Revolutionizing Textile Innovation with Natura Acme Mills Company, a recognized pioneer in textile manufacturing, has proudly unveiled its latest innovation, Natura. This new line of bio-based polylactic acid (PLA) fabrics aims to replace traditional petroleum-based materials such as PET, PP, and Nylon. With Natura, Acme Mills is not just promoting a product; it is...
Continue Reading
Opportunity for C3.ai, Inc. Shareholders to Join Class Action Attention, shareholders of C3.ai, Inc. (NYSE: AI). A significant class action suit is currently underway, and your involvement could be crucial. If you purchased shares during the class period, there may be an opportunity for you to participate in a recovery process without the requirement of being a lead...
Continue Reading
EyePoint Pharmaceuticals Set to Showcase Q2 Financials EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pioneering company dedicated to developing advanced therapeutics for serious retinal diseases, plans to share its second quarter 2025 financial results. This announcement will be accompanied by a live conference call and webcast on a scheduled day, promising to provide...
Continue Reading